Clinical trials
TB clinical trials
Below are recruiting tb clinical trials, each written for real people, not researchers. We’re tracking 71 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07164742Recruiting
Recovery help for lung health after TB treatment
This study tests whether a lung rehabilitation program (like physical therapy for your lungs) can help people who recently started TB treatment breathe and feel better. You need a smartphone and must be willing to attend sessions for 48 weeks.
MangaloreAges 18 years+ - NCT07460843Recruiting
Comparing two types of prostate biopsy for diagnosis
This study compares two methods of taking prostate biopsy samples (TB+PB vs TB+6SB) to see which is better at diagnosing prostate cancer. It is for men who have a suspicious spot on their MRI and meet certain PSA or exam criteria.
Beijing, Beijing MunicipalityAges 18–85 - NCT06314386Enrolling by invitation
Improving TB prevention in Eastern Cape clinics
This study looks at how to improve TB prevention in rural and semi-urban clinics in South Africa. They will work with clinic staff and district leaders to find better ways to stop TB.
AddoAges birth+ - NCT06719193RecruitingPhase 2/Phase 3
TB study for all ages in Ethiopia
This trial is testing a new way to find and treat tuberculosis (TB) in communities in Ethiopia. It aims to help people of any age who live in certain areas get better care.
West Arsi Zone, Ormoia Regional StateAges Any age - NCT07208240RecruitingPhase 1/Phase 2
PSMA-targeted radiation before prostate removal for advanced cancer
This trial tests giving a radioactive drug (PSMA-targeted) before surgery for prostate cancer that has spread locally but not to other parts of the body. The goal is to see if it helps lower the risk of the cancer coming back.
Petah TikvaAges 18 years+ - NCT05493267RecruitingPhase 4
Tested immune-cell therapy for drug-resistant tuberculosis
This trial studies an immune-based treatment made from certain T cells (Vγ2Vδ2 T lymphocytes) for multi-drug–resistant tuberculosis (MDR-TB). It may help people whose current drug regimen is not working well or who have limited effective options.
ShanghaiAges 18–65 - NCT05521412RecruitingPhase 1/Phase 2
PSMA-targeted radioligand for advanced prostate cancer
This Phase 1/2 trial tests a PSMA-targeted radioligand treatment (a drug that delivers radiation to prostate cancer cells) in men with metastatic castration-resistant prostate cancer that has gotten worse despite standard hormone therapies. It’s designed to see how the treatment works and whether it can help shrink or control cancer, while also studying safety and dosing.
Melbourne, VictoriaAges 18 years+ - NCT05917210Recruiting
Peer support for TB and HIV treatment in Uganda
This trial tests a peer-led education and counseling program to help people with TB and HIV stick with their treatment. It may help improve understanding, motivation, and day-to-day adherence to medications.
KampalaAges 18 years+ - NCT07672405RecruitingPhase 2
Sorfequiline-based treatment for new drug-sensitive TB
This study tests a new medicine called sorfequiline, given in a combination regimen, to treat adults with drug-sensitive TB. It aims to see if sorfequiline can work as well as or better than standard treatment and shorten the time to cure.
Port Elizabeth, BethelsdorpAges 18–65 - NCT07227779RecruitingPhase 2
B-PaLMZ for TB meningitis in people with HIV
This trial tests a combination of TB medicines (B-PaLMZ) for people with HIV who have their first episode of TB meningitis. It aims to find a better treatment option.
KampalaAges 18 years+ - NCT05081401RecruitingPhase 3
All-oral shorter treatment for rifampicin-resistant TB
This Phase 3 trial tests a shorter, all-pill (oral) treatment plan for people with rifampicin-resistant pulmonary tuberculosis. It aims to improve treatment while reducing the burden of therapy, using a plan tailored to the individual.
Guiyang, GuizhouAges 16–75 - NCT05671718Recruiting
Nurse vs doctor treatment for drug-resistant tuberculosis
This trial compares a nurse-led plan versus a physician-led plan for treating new drug-resistant TB patients using an outpatient clinic approach. It may help by showing which care style works best and is safest for patients starting treatment close to home.
Pietermaritzburg, KwaZulu-NatalAges 18 years+ - NCT05989802Recruiting
Testing new TB tests for children
This study is testing new ways to quickly diagnose TB in children under 15. It aims to find better tests that can be used at clinics, especially for kids who may not have obvious symptoms.
MaputoAges Up to 65 years - NCT06017843Recruiting
Using AI to find TB cases in community camps
This trial tests whether an AI tool can help find undiagnosed tuberculosis (TB) faster in community camps. If you are over 15 and visiting a camp site, you may be able to join and help improve TB detection.
IslamabadAges 15 years+ - NCT06221488Recruiting
TB testing for health workers at risk
This study tests health workers for tuberculosis (TB) infection to better understand who is at risk. It may help find ways to protect health workers from TB.
Cape TownAges 18–100 - NCT06272812RecruitingPhase 2
TB vaccine study for teens and adults
This trial tests whether a new vaccine called MTBVAC can prevent tuberculosis (TB) in people living in areas where TB is common. If you are between 14 and 45 years old and in good health, you may be able to join.
KisumuAges 14–45 - NCT06476210RecruitingPhase 4
New drug combo for drug-resistant tuberculosis
This trial tests a three-drug combination (bedaquiline, delamanid, and linezolid) to see if it's safe and works well for people with multi-drug resistant or rifampicin-resistant tuberculosis. It may offer a new treatment option if standard drugs aren't working.
Hefei, AnhuiAges 18 years+ - NCT06482645Recruiting
Testing a new biopsy method for prostate cancer diagnosis
This study is testing a new approach to prostate biopsy that takes samples from around a suspicious area seen on MRI. It aims to see if this method can better detect prostate cancer compared to standard biopsy.
Beijing, Beijing MunicipalityAges 45–85 - NCT06497465RecruitingPhase 3
HIV study for people starting TB treatment
This trial tests a two-drug HIV treatment (dolutegravir and lamivudine) for people who also have active TB and are taking a standard TB medicine called rifampin. It is designed for those who have not yet started HIV treatment.
Manaus, AmazonasAges 15–99 - NCT06700876Recruiting
TB test study for kidney disease or transplant patients
This study looks at better ways to find hidden (subclinical) tuberculosis (TB) in people with serious kidney disease or those who have had a kidney transplant. If you have kidney failure on dialysis or have a kidney transplant, you may qualify and help improve TB detection.
BangkokAges 18 years+ - NCT06706596Recruiting
TB screening for high-risk groups in Barcelona
This trial offers free tuberculosis (TB) testing for people who are at high risk for the disease. It aims to find TB early so it can be treated quickly.
BadalonaAges Any age - NCT06796647Recruiting
TB skin test for patients with rheumatologic conditions
This trial is testing a new type of skin test (called ESAT6/CFP10) to check for TB infection in people who have a rheumatologic disease and are about to start certain medications (b/tsDMARDs). The goal is to see if this skin test works well for these patients.
Hong Kong, Hong KongAges 18–65 - NCT06909799Recruiting
NAC to prevent lung damage after TB treatment
This trial tests if taking N-acetylcysteine (NAC) alongside standard TB treatment can help prevent long-term lung problems after tuberculosis. It is for people with moderate to severe TB who already have some reduced lung function.
Fajara, The GambiaAges 18–65 - NCT06916962Recruiting
Supporting TB recovery: The UPLIFT trial
This trial is studying if offering extra support to people being treated for tuberculosis (TB) can help them recover and feel better overall. It's for people who have started treatment for drug-sensitive TB and live in certain areas.
Ba Ria Vung TauAges 18 years+
Hear when a new TB trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for tb?
- Yes. Clin2 currently lists 71 recruiting tb studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a tb trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a tb trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.